Related Experiment Video

Updated: Aug 15, 2026

An Orthotopic Murine Model of Human Prostate Cancer Metastasis
06:48

An Orthotopic Murine Model of Human Prostate Cancer Metastasis

Published on: September 19, 2013

Some effects of inhibitors of polyamine synthesis on experimental prostatic cancer

U Dunzendorfer, N Releyea, W F Whitmore

    Arzneimittel-Forschung
    |January 1, 1984
    PubMed

    Insights

    Difluoromethylornithine (DFMO) effectively reduced prostate cancer tumor size in experimental models. Methylglyoxal-bis(guanyl-hydrazone) (MGBG) also reduced tumor size but showed high toxicity.

    Area of Science:

    • Oncology
    • Pharmacology
    • Biochemistry

    Background:

    • Prostate cancer remains a significant health concern, necessitating novel therapeutic strategies.
    • Enzyme inhibitors targeting polyamine biosynthesis pathways are potential anticancer agents.

    Purpose of the Study:

    • To evaluate the efficacy of Difluoromethylornithine (DFMO) and methylglyoxal-bis(guanyl-hydrazone) (MGBG) in experimental prostate cancer models.
    • To assess the impact of these inhibitors on tumor growth and enzyme activity.

    Main Methods:

    • Testing DFMO and MGBG in rat R-3327 adenocarcinoma and human DU-145 adenocarcinoma models.
    • Measuring tumor size reduction and assessing toxicity of the agents.
    • Investigating the role of ornithine decarboxylase (ODC) levels.

    Main Results:

    • DFMO significantly reduced tumor size in both rat and human prostate cancer models.
    • MGBG reduced tumor size in the rat model but exhibited significant toxicity.
    • Flutamide and 9-B-D-arabinofuranosyladenine (Ara-A) showed limited efficacy alone but enhanced DFMO's effect on DU-145 tumors.

    Conclusions:

    • DFMO demonstrates therapeutic potential for prostate cancer, particularly in tumors with high ODC activity.
    • MGBG's toxicity limits its clinical utility.
    • Combination therapy with DFMO may enhance treatment outcomes for specific prostate cancer types.

    More Related Videos

    Murine Prostate Micro-dissection and Surgical Castration08:49

    Murine Prostate Micro-dissection and Surgical Castration

    Published on: May 11, 2016

    A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer07:25

    A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

    Published on: March 6, 2018

    Related Concept Videos

    Drugs that Stabilize Microtubules01:15

    Drugs that Stabilize Microtubules

    Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
    Combined Effects of Drugs: Synergism01:27

    Combined Effects of Drugs: Synergism

    Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
    Such synergistic combinations...
    Drugs Affecting Neurotransmitter Synthesis01:29

    Drugs Affecting Neurotransmitter Synthesis

    Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase, which converts...
    Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors01:28

    Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors

    Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH).
    Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
    Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists01:23

    Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists

    Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
    These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
    Inhibitors of Viral Protein Synthesis01:30

    Inhibitors of Viral Protein Synthesis

    Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...